Hong Kong creates coin-sized wearable biosensing platform

A team of researchers from the Faculty of Engineering of The University of Hong Kong (HKU) has developed a coin-sized sy...

August 12, 2022 | Friday | News
Insilico Medicine raises $95 M to further expand AI capabilities

Hong Kong-based startup Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discover...

August 11, 2022 | Thursday | News
Asieris appoints Dr Badrinath Konety to scientific advisory board

China's Asieris Pharmaceuticals, a global biopharma company specializing in discovering and developing innovative drugs ...

August 10, 2022 | Wednesday | News
Prenetics unveils at-home blood tests using painless, push-button collection device

Hong Kong-based startup Prenetics has announced the launch of Circle Snapshot, a variety of at-home blood tests that fea...

August 9, 2022 | Tuesday | News
WeTrade Group to sell monkeypox test kit globally

WeTrade Group, an emerging growth company engaged in the business of providing software-as-a-services (SAAS) and cloud i...

August 9, 2022 | Tuesday | News
BioDuro-Sundia and X-Chem focus on new small molecule drug discovery in China

BioDuro-Sundia, an industry-leading drug discovery, development and commercial service contract research development and...

August 8, 2022 | Monday | News
Chinese startup Epigenic Therapeutics raises funding worth $20 M

China's Epigenic Therapeutics has secured $20 million in Series Angel and Pre-A funding. Series Pre-A funding is jointly...

August 8, 2022 | Monday | News
Innovent Biologics, Sanofi to develop cancer medicines for China

Innovent Biologics and Sanofi have announced a collaboration to bring innovative medicines to patients in China with dif...

August 5, 2022 | Friday | News
PolyU-led key study on air pollution & health receives HK $44.5 M funding

A key research on air fine particulate pollution and health led by The Hong Kong Polytechnic University’s (PolyU) ...

August 3, 2022 | Wednesday | News
Sironax raises $200 M in series B financing for pipeline expansion

China-based biotech startup Sironax, dedicated to the discovery and global development of novel treatments for patients ...

August 3, 2022 | Wednesday | News
OriCell Therapeutics raises over $120 M to advance cell therapies for cancer immunology

China-based startup OriCell Therapeutics has announced the completion of Series B financing totaling over $120 mill...

August 4, 2022 | Thursday | News
Nippon Express opens new healthcare branch in Shanghai

Nippon Express has established a Healthcare Branch in Shanghai to strengthen its efforts in China's pharmaceutical indus...

August 1, 2022 | Monday | News
China's Kelun-Biotech inks oncology pact worth $936 M with Merck

China's Kelun-Biotech, a clinical-stage biotech company focused on biologic and small molecule discovery and development...

August 2, 2022 | Tuesday | News
Apollomics expands leadership team with appointment of Dr Jane Wang as CSO

China's Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and...

July 26, 2022 | Tuesday | News
INEX Innovate backs Chinese University of Hong Kong for foetal medicine research

Singapore-based diagnostics developer and medical laboratory operator INEX Innovate has contributed an undisclosed sum t...

July 26, 2022 | Tuesday | News
China's Rona Therapeutics advances development of Sanofi's siRNA portfolio

China-based startup Rona Therapeutics has obtained worldwide exclusive rights to Sanofi's siRNA platform of chemical mod...

July 25, 2022 | Monday | News
Hong Kong calls for prevention of cerebral small vessel disease to lower stroke risk

The Division of Neurology at The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) conduc...

July 22, 2022 | Friday | News
Hong Kong develops bioinformatics tool to predict COVID-19 vaccine effectiveness against variants

Timely evaluation of COVID-19 vaccine effectiveness (VE) is desperately needed to inform and update vaccine design as no...

July 19, 2022 | Tuesday | News
Brii Bio advances commercialisation of COVID-19 neutralizing antibody therapy in China

Brii Biosciences has announced that TSB Therapeutics (Beijing),  a joint venture majority-owned by the company, is ...

July 19, 2022 | Tuesday | News
China approves world's first comprehensive myeloprotection drug against chemo damage

Simcere Pharmaceuticals has announced that the China National Medical Products Administration (NMPA) has conditionally a...

July 18, 2022 | Monday | News
Basecare Medical and Haier Biomedical to build cryopreservation solutions for assisted reproduction

Suzhou Basecare Medical Corporation has entered into a strategic collaboration framework agreement with Qingdao Hai...

July 15, 2022 | Friday | News
Merck launches uptune programme in Asia for collaborating with startups

Merck has announced the launch of its Uptune programme in Asia, which aims to generate collaboration opportunities with ...

July 15, 2022 | Friday | News
SINOVAC COVID-19 vaccine gets EUA for kids aged 3-5 in Brazil

Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced that its COVID-19 vaccine (Cor...

July 15, 2022 | Friday | News
Triastek, Eli Lilly explore 3D printing for oral drug delivery

China-based startup Triastek has announced a collaboration with Eli Lilly and Company to leverage the advantages of 3D p...

July 14, 2022 | Thursday | News
TiktTok owner enters life sciences, invests in Shuimu BioSciences

ByteDance, developer of the video-sharing social networking services and apps TikTok, has pitched into life science...

July 13, 2022 | Wednesday | News
Athenex sells Chinese API business for $19 M

Athenex, Inc., a global biopharmaceutical company dedicated to the discovery, development, and commercialization of nove...

July 12, 2022 | Tuesday | News
Hong Kong links non-invasive eye stimulation with depression and dementia

A joint research team from Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKUMed) and City ...

July 8, 2022 | Friday | News
Japan's Shionogi seeks China approval for COVID-19 treatment

Shionogi & Co., has announced that a joint venture between Shionogi and Ping An Life Insurance Company of China, , P...

July 8, 2022 | Friday | News
Huili Biotechnology completes Series A financing

Jiangsu Huili Biotechnology, a next-generation synthetic biology enzyme computational design platform, has recently anno...

July 8, 2022 | Friday | News
Brii Biosciences launches long-acting COVID-19 neutralizing antibody therapy in China

Brii Biosciences, a multi-national company developing innovative therapies for diseases with significant unmet medi...

July 11, 2022 | Monday | News
WuXi STA opens new large-scale oligonucleotide and peptide manufacturing facility

WuXi STA, a subsidiary of China-based WuXi AppTec, has announced the opening of a new large-scale oligonucleotide and pe...

July 7, 2022 | Thursday | News
Sinovac starts Omicron-specific inactivated vaccine trial for booster use in China

A kick off ceremony was held at Gleneagles Hospital Hong Kong (Gleneagles or GHK) for initiating a clinical trial to ass...

July 5, 2022 | Tuesday | News
WuXi STA opens another high-potency API plant in China

WuXi STA, a WuXi AppTec company, has opened another high-potency API (HPAPI) plant at its Changzhou site (Jiangsu, China...

July 1, 2022 | Friday | News
Eurofins DiscoverX expands APAC operations with new biotech office in China

Eurofins DiscoverX Products LLC, a global industry leader in products for small and large molecule drug discovery a...

July 4, 2022 | Monday | News
China's COVID-19 Homologous Booster demonstrates cross-neutralization against Omicron

China's Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing novel vaccines and biol...

June 29, 2022 | Wednesday | News
Fosun Pharma, Amgen collaborate to bring two innovative medicines to Chinese patients

Fosun Pharma and Amgen have jointly announced a collaboration and license agreement for Fosun Pharma for the commerciali...

June 29, 2022 | Wednesday | News
Chinese University of Hong Kong receives HK$150 support for biomedical research

The Chinese University of Hong Kong (CUHK) has received a generous donation of HK$150 million from the Li Ka Shing Found...

June 28, 2022 | Tuesday | News
JOYSBIO develops antigen rapid test to detect Omicron subvariants BA.4 and BA.5

As the SARS-COV-2 Omicron subvariants BA.4 and BA.5 make their way across the EU and the US, China-based Joysbio has dev...

June 27, 2022 | Monday | News
China approves treatment for chronic non-infectious eye inflammation

Ocumension Therapeutics has announced that the New Drug Application (NDA) for the core product in its pipeline, OT-401 (...

June 23, 2022 | Thursday | News
Hong Kong pushes biomedical technology development to nurture startups

Hong Kong Science and Technology Parks Corporation (HKSTP) is partnering with global research-driven biopharmaceutical l...

June 21, 2022 | Tuesday | News
New study contributes to clinical diagnosis and intervention in mite allergies in China

The medically important astigmatic mites have long been known as the major cause of human allergies. Recently, a groundb...

June 17, 2022 | Friday | News
Chinese antibody drug for cancer to be produced and marketed in Indonesia

On June 14, two of Legend Capital's portfolio companies, Innovent Biologics, Inc. and PT Etana Biotechnologies Indonesia...

June 15, 2022 | Wednesday | News
CPHI China opens for international partnering after China rises in CPHI Index

CPHI & P-MEC China opens its online international partnering platform as pharmaceutical and biopharmaceutical i...

June 15, 2022 | Wednesday | News
Hong Kong opens Centre for Eye and Vision Research

At the forefront of the population’s health and aging imperative and with its mission of generating innovative tec...

June 13, 2022 | Monday | News
China's SINOVAC polio vaccine receives WHO prequalification

SINOVAC Biotech, a leading provider of biopharmaceutical products in China, has received the World Health Organization (...

June 10, 2022 | Friday | News
Insilico Medicine raises $60 M to launch AI-powered drug discovery robotics lab

US and Hong Kong-based startup Insilico Medicine has completed a $60 million Series D financing from a syndicate of...

June 7, 2022 | Tuesday | News
WuXi Biologics launches first commercial drug product facility for pre-filled syringes in China

WuXi Biologics, a global contract research, development and manufacturing organisation (CRDMO) service company, has succ...

June 6, 2022 | Monday | News
Booster shot key to protect against Omicron infection: Hong Kong study

The efficacy and effectiveness of individual vaccine products for COVID-19 and its variants of concern are well known. H...

June 3, 2022 | Friday | News
Hong Kong finds way to measure vaccine effectiveness in absence of adequate health data

A research team from the Hong Kong University of Science and Technology (HKUST) has demonstrated how to measure vaccine ...

June 2, 2022 | Thursday | News
China's Zelixir Biotech predicts monkeypox protein structures for drug discovery

Zelixir Biotech, based in China, has predicted more than 600 structures and added functional annotations of proteins fro...

May 31, 2022 | Tuesday | News
China promotes modernisation and internationalisation of traditional medicine

Hong Kong Baptist University (HKBU) and China Resources Enterprise Limited (CRE) have signed a Memorandum...

May 30, 2022 | Monday | News
Hong Kong designs ultrasensitive and portable COVID-19 antibody detection sensor

A research team from the Department of Applied Physics of The Hong Kong Polytechnic University (PolyU) has successfully ...

May 27, 2022 | Friday | News
Insilico Medicine explores use of 3CL protease inhibitor for COVID-19 treatment

Insilico Medicine, a China & US-based clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery c...

May 25, 2022 | Wednesday | News
New Horizon Health partners with Prenetics to launch non-invasive colon cancer test

New Horizon Health and Prenetics has announced a strategic partnership to launch ColoClear by Circle, the "First Colorec...

May 24, 2022 | Tuesday | News
VerImmune and Fosun Pharma focus on virus-inspired particle based novel immunotherapies in China

US-based  startup VerImmune and Fosun Pharma in China have entered into an exclusive license and option agreement. ...

May 23, 2022 | Monday | News
WHO validates China's Convidecia as 11th vaccine for COVID-19

The World Health Organization (WHO) has issued an emergency use listing (EUL) for Convidecia, a vaccine manufactured by ...

May 20, 2022 | Friday | News
China-based Jiangsu Hengrui Pharma launches new subsidiary Luzsana Biotech

Chinese firm Jiangsu Hengrui Pharmaceuticals has announced that it is launching Luzsana Biotechnology (Luzsana), a globa...

May 19, 2022 | Thursday | News
Fujifilm completes construction of bioprocessing innovation & collaboration centre in China

FUJIFILM Irvine Scientific, Inc. has announced the completion of its Innovation and Collaboration Centre in Suzhou ...

May 19, 2022 | Thursday | News
INVO Bioscience targets fertility market in China

INVO Bioscience, Inc., focused on expanding access to advanced treatment worldwide with its INVOcell medical device...

May 17, 2022 | Tuesday | News
BeiGene strengthens European presence with new office in Basel, Switzerland

China's BeiGene has announced the opening of a new regional office in Basel, Switzerland. BeiGene has built a European o...

May 17, 2022 | Tuesday | News
Study in Hong Kong shows robust antibody generation post-vaccination as compared to natural infection

A recent study jointly conducted by the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and the Faculty of...

May 16, 2022 | Monday | News
AskGene raises $20 Million in Series A

China & US-based startup AskGene has announced the completion of $20 million in Series A financing. The financing wa...

May 11, 2022 | Wednesday | News
China's OPPO Research Institute calls for innovative proposals on digital health

China-based company OPPO has announced the OPPO Research Institute Innovation Accelerator to empower technology professi...

May 10, 2022 | Tuesday | News
China-based startup InxMed raises $15 M to advance therapies for drug-resistant cancers

InxMed, a Chinese clinical-stage biotechnology company dedicated to developing innovative therapies targeting ...

May 9, 2022 | Monday | News
Orion partners with Jemincare for novel non-opioid drug candidate for pain treatment

Finland's Orion Corporation has entered into an agreement with Chinese Jemincare, through which Orion will receive exclu...

May 6, 2022 | Friday | News
EyePoint Pharma with Betta Pharma lay focus on eye diseases across the globe

EyePoint Pharmaceuticals has announced the execution of a license agreement with Betta Pharmaceuticals to develop and co...

May 5, 2022 | Thursday | News
China approves phase 2 trial of recombinant protein COVID-19 vaccine, ReCOV

Jiangsu Recbio Technology Co., Ltd. has recently received the clinical trial approval for its recombinant protein COVID-...

May 5, 2022 | Thursday | News
China holds significant dominance in Asia breast cancer screening market: Report

According to the ResearchAndMarkets.com recent report, Asia Breast Cancer Screening Market is expected to reach $16...

May 4, 2022 | Wednesday | News
Hong Kong links gut microbial enzymes with colon inflammation

A Hong Kong Baptist University (HKBU) collaborative research study has revealed that certain gut microbial enzymes media...

May 4, 2022 | Wednesday | News
NiKang Therapeutics, Hansoh Pharma ink $200M worth deal for cancer treatment in Greater China

NiKang Therapeutics , a clinical stage biotech company focused on developing innovative small molecule oncology medicine...

May 4, 2022 | Wednesday | News
China Mobile Hong Kong launches online medical app "Dr. HK"

China Mobile Hong Kong (CMHK) has announced the launch of "Dr. HK", an online doctor consultation and medical app p...

May 4, 2022 | Wednesday | News
Zhifei Lvzhu Biopharmaceutical to commercialise whooping cough vaccine in China

Intravacc B.V., located at Utrecht Science Park Bilthoven in the Netherlands, has announced the signing o...

May 3, 2022 | Tuesday | News
China-based Biocytogen enters into antibody agreement with Merck

China's Biocytogen Pharmaceuticals has entered into an evaluation and option agreement with Merck to grant them a sole l...

May 2, 2022 | Monday | News
China-based I-Mab appoints new COO and CMO

China's I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...

April 29, 2022 | Friday | News
Visirna brings RNAi therapeutics for cardiovascular & metabolic diseases in Greater China

US-based Arrowhead Pharmaceuticals, Inc. has formed a joint venture, Visirna Therapeutics, with Vivo Capital t...

April 29, 2022 | Friday | News
Hong Kong holds first clinical trial of novel oral treatment for COVID-19

The Chinese University of Hong Kong (CUHK)’s Clinical Trial Centre has announced its collaboration with CUHK Medic...

April 28, 2022 | Thursday | News
China's Antengene looks to start phase I trial in Australia

China's Antengene Corporation, a leading innovative, commercial-stage global biopharmaceutical company dedicated to disc...

April 27, 2022 | Wednesday | News
Lupin partners with Yabao Pharma for paediatric formulations in China

Indian firm Lupin has entered into a strategic partnership with Yabao Pharmaceutical Co, to meet the growing demand for ...

April 27, 2022 | Wednesday | News
China releases first international COVID-19 testing standard

According to the State Administration for Market Regulation in China, the International Organization for Standardization...

April 26, 2022 | Tuesday | News
Startups accelerate cell therapy development for solid tumours in China

China-based startups Suzhou Porton Advanced Solutions and Guizhou Sinorda Biomedicine have announced a long-term strateg...

April 25, 2022 | Monday | News
Wallaby acquires German neurovascular leader Phenox to accelerate global expansion

Wallaby Medical, a global innovative medical technology company focused on developing and commercializing neurovascular ...

April 22, 2022 | Friday | News
Lynk Pharmaceuticals gets clinical approval in China for Class I New Drug LNK01004

Lynk Pharmaceuticals, an innovative clinical stage company, has announced that its Class I innovative drug LNK01004, has...

April 22, 2022 | Friday | News
ATUM accelerates entry of bioengineering solutions into Chinese pharmaceutical market

US-based ATUM has announced a distribution partnership with Trio Biotech to market and promote ATUM’s unique Leap-...

April 21, 2022 | Thursday | News
China's ImmVira partners with Roche for cancer therapy

China-based startup ImmVira has reached a cooperation agreement with Roche to establish clinical research partnership re...

April 20, 2022 | Wednesday | News
AmoyDx collaborates with AstraZeneca for multiple companion diagnostics in China

Amoy Diagnostics, a China based innovative molecular diagnostics company, has entered into a Master Collaboration A...

April 19, 2022 | Tuesday | News
GeneQuantum and AIMEDBIO collaborate on a first-in-class antibody drug conjugate

China's GeneQuantum Healthcare, a company specializing in site-specific bioconjugation for next generation biotherapeuti...

April 19, 2022 | Tuesday | News
VectorBuilder invests $500 M in gene delivery research & manufacturing campus in China

US-based VectorBuilder Inc. has announced the construction of a new R&D and manufacturing centre in Guangzhou, China...

April 18, 2022 | Monday | News
China's SonoScape receives FDA 510(k) clearance for HD-550 Endoscopy system

SonoScape announced that the U.S. Food and Drug Administration (FDA) has approved its flagship video endoscopy system HD...

April 18, 2022 | Monday | News
China approves Fosun Diagnostics' COVID-19 antigen detection kit

Shanghai Fosun Pharmaceutical (Group) has announced that the novel coronavirus (2019-nCoV) antigen detection kit (Colloi...

April 15, 2022 | Friday | News
Hong Kong develops portable nucleic acid testing device for COVID-19

In 2020, an interdisciplinary research team from The Hong Kong Polytechnic University (PolyU) was awarded over HK$2.7 mi...

April 14, 2022 | Thursday | News
Harbour BioMed appoints Dr Humphrey Gardner as Chief Medical Officer

Harbour BioMed has announced the appointment of Dr Humphrey Gardner as Chief Medical Officer (CMO). Dr Gardner...

April 14, 2022 | Thursday | News
UAE approves late stage trial of Jiangsu's COVID-19 vaccine

China's Jiangsu Recbio Technology has received approval from the Ministry of Health and Prevention of the United Arab Em...

April 13, 2022 | Wednesday | News
BRV China-backed exoskeleton startup RoboCT secures RMB100 million

Hangzhou RoboCT Technology Development Co., Ltd., a global leading exoskeleton company, recently completed RMB100 millio...

April 13, 2022 | Wednesday | News
VenusP-Valve obtains CE marking under MDR and debuts in Europe as China's first valve product

VenusP-Valve, Venus Medtech's in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, rece...

April 12, 2022 | Tuesday | News
Hong Kong discovers distinct gut microbial signatures for 'long COVID'

Clinical researchers from The Chinese University of Hong Kong's (CUHK) Faculty of Medicine (CU Medicine) have identified...

April 11, 2022 | Monday | News
Biocytogen signs RenMab/RenLite licensing agreement with BeiGene

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. have reached an agreement with BeiGene (Beijing) for licensing of Biocyto...

April 11, 2022 | Monday | News
CARsgen appoints Dr Raffaele Baffa as Chief Medical Officer

China's CARsgen Therapeutics Holdings, a company focused on innovative CAR T cell therapies for the treatment of hematol...

April 8, 2022 | Friday | News
SeekIn receives CE Mark approval for LeukoPrint molecular karyotyping test

SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, has announced the CE (Conformit&...

April 8, 2022 | Friday | News
Chinese firms strengthen focus on development and commercialisation of mRNA vaccines

Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...

April 7, 2022 | Thursday | News
Rona Therapeutics raises $33 million in Series A

China-based startup Rona Therapeutics announces the successful completion of $33 million Series A financing to advance p...

April 7, 2022 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls